Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
AstraZeneca
Queensland Health
Mallinckrodt
Medtronic

Generated: July 20, 2019

DrugPatentWatch Database Preview

Patent: RE45174

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: RE45174
Title:Thiazolidin-4-one derivatives
Abstract: The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.
Inventor(s): Binkert; Christoph (Basel, CH), Bolli; Martin (Allschwil, CH), Mathys; Boris (Egerkingen, CH), Mueller; Claus (Weil am Rhein, DE), Scherz; Michael (Ettingen, CH), Nayler; Oliver (Arlesheim, CH)
Assignee: Actelion Pharmaceuticals Ltd. (Allschwil, CH)
Application Number:14/028,712
Patent Claims:see list of patent claims

Details for Patent RE45174

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Biogen ZINBRYTA daclizumab INJECTABLE;INJECTION 761029 001 2016-05-27 ➤ Try a Free Trial Actelion Pharmaceuticals Ltd. (Allschwil, CH) ➤ Try a Free Trial RX search
Novartis SIMULECT basiliximab VIAL; SINGLE-USE 103764 002 1998-05-12 ➤ Try a Free Trial Actelion Pharmaceuticals Ltd. (Allschwil, CH) ➤ Try a Free Trial RX search
Novartis SIMULECT basiliximab VIAL; SINGLE-USE 103764 001 1998-05-12 ➤ Try a Free Trial Actelion Pharmaceuticals Ltd. (Allschwil, CH) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent RE45174

Country Patent Number Publication Date
South Africa 200605077 May 30, 2007
World Intellectual Property Organization (WIPO) 2005054215 Jun 16, 2005
United States of America 2007082933 Apr 12, 2007
United States of America 2008146629 Jun 19, 2008
United States of America 2008280962 Nov 13, 2008
United States of America 2009275625 Nov 05, 2009
United States of America 2012302612 Nov 29, 2012
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Daiichi Sankyo
Argus Health
Cipla
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.